Login / Signup

Prognoses of patients with melanoma who continue/discontinue anti-programmed death-1 therapy after achieving a complete response in a real-world setting: a multicentre retrospective study.

Junji KatoKenjiro NamikawaJiro UeharaMotoo NomuraYasuhiro NakamuraHisashi UharaHiroshi UchiShusuke YoshikawaYukiko KiniwaYoshiyuki NakamuraTakuya MiyagawaShigeto MatsushitaTatsuya TakenouchiNaohito HattaFumitaka OhnoTaku MaedaSatoshi FukushimaNaoya Yamazaki
Published in: The British journal of dermatology (2022)
Keyphrases
  • clinical trial
  • study protocol
  • cross sectional
  • randomized controlled trial
  • double blind
  • stem cells
  • basal cell carcinoma